FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula I, as well as to a pharmaceutical composition for treating a disease or medical condition mediated by N2RA activity, comprising an effective amount of a compound of formula I and a pharmaceutically acceptable carrier.
EFFECT: disclosed are pyridopyrimidinones and use thereof as n-methyl-d-aspartate receptor modulators.
22 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FLUORINE-18 AND CARBON-11 LABELED RADIOLIGANDS FOR POSITRON EMISSION TOMOGRAPHY (PET) IMAGING FOR LRRK2 | 2012 |
|
RU2650641C2 |
| AMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS | 2012 |
|
RU2651544C2 |
| PYRAZOLAMINOPIRIMIDINE DERIVATIVES AS LEUCINE-REPEATING KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON DISEASE | 2013 |
|
RU2637948C2 |
| 2-PHENYLAMINOPYRIMIDINE DERIVATIVES AS LEUCINE-RICH REPEAT KINASE 2 (LRRK2) MODULATORS FOR TREATMENT OF PARKINSON'S DISEASE | 2012 |
|
RU2661197C2 |
| THIAZOLOPYRIMIDINONES AS MODULATORS OF NMDA RECEPTOR ACTIVITY | 2014 |
|
RU2703273C2 |
| PYRAZOLE-BASED MAGL INHIBITORS | 2018 |
|
RU2789157C2 |
| AMINOPYRIDINE DERIVATIVES AS MODULATORS OF LEUCINE-RICH REPEATED KINASE 2 (LRRK2) | 2012 |
|
RU2634716C2 |
| HETEROARYL PYRROLIDINYL AND PIPERIDINYL KETONE DERIVATIVES | 2007 |
|
RU2479575C2 |
| THIENOPYRIMIDINE DIONES AND THEIR USE IN MODULATION OF AUTOIMMUNE DISEASE | 2004 |
|
RU2331647C2 |
| IMIDAZO[1,2-A]PYRIDINE AND PYRAZOLE[2,3-A]PYRIDINE DERIVATIVES | 2000 |
|
RU2248976C2 |
